Rollo Capital Management Company Profile, Contacts & Intelligence

Rollo Capital Management Overview

Rollo Capital Management ("RCM") is a Boston-based investment firm established in January 2008 and focused on industrial sectors, with an emphasis on materials, capital goods, chemicals, technology, automotive, energy and aerospace. RCM is the manager and advisor of CIP (Change in Progress), LP, an investment partnership pursuing medium and long-term investment strategies in publicly-listed industrial companies with an emphasis on change and innovation and with a value-based philosophy. RCM is also the manager of RCV I, LLC, an investment vehicle focused on early-stage innovative companies in the areas of materials and automation. Portfolio investments include: Gelesis (NYSE: GLS), enEvolv (acquired by Zymergen; NYSE: ZY), Continuus Pharmaceuticals (www.continuuspharma.com), PanTher Therapeutics (www.panthertx.com), Pearl Bio (pearlbio.com).

Headquarters

Boston, United States

Website

rollocapital.com

Industry

Financial Services

Founded

2008

Stock Symbol

GLS

NAICS

Finance and Insurance, Monetary Authorities-Central Bank

Company Email

Available in AeroLeads

Rollo Capital Management Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Compare Similar Companies to Rollo Capital Management

Explore companies in related markets and compare their industry and employee estimates.